C200 schreef op 13 november 2018 10:50:
Kiadis Pharma to present at upcoming investor conferences in November 2018
Amsterdam, The Netherlands, November 13, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announces that it is scheduled to present at the following investor conferences in November 2018.
Jefferies London 2018 Healthcare Conference
November 14-15, London, UK
Arthur Lahr, CEO, will present on November 14, 2:00pm GMT and will host meetings with institutional investors.
A live webcast of the presentation will be available here:
wsw.com/webcast/jeff115/kds/ An archived replay of the webcast will be available on the Company's website for 90 days following the presentation.
Piper Jaffray 30th Annual Healthcare Conference
November 27-29, New York, USA
Arthur Lahr, CEO, will present on November 27, 4:30pm ET, and will host meetings with institutional investors.
A live webcast of the presentation will be available here:
event.webcasts.com/starthere.jsp?ei=1...An archived replay of the webcast will be available on the Company's website for approximately 90 days following the presentation.